Hydroxyzine inhibits experimental allergic encephalomyelitis (EAE) and associated brain mast cell activation

International Journal of Immunopharmacology

Volumn 22, Issue 9, 2000, Pages 673-684

  Dimitriadou, Violetta ^a   Pang, Xinzhu ^b   Theoharides, Theoharis C ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Brain; Demyelination; Encephalomyelitis; Hydroxyzine; Inflammation; Mast cells; Multiple sclerosis; Secretion

Indexed keywords

HYDROXYZINE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DEMYELINATING DISEASE; FEMALE; IMMUNOCYTOCHEMISTRY; MAST CELL DEGRANULATION; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; THALAMUS;

ANIMALS; BRAIN; CELL DEGRANULATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HISTAMINE H1 ANTAGONISTS; HYDROXYZINE; MAST CELLS; RATS; RATS, INBRED LEW; RECEPTORS, IGE;

EID: 0034286991     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(00)00029-1     Document Type: Article

References (85)

1. Ffrench-Constant C. Pathogenesis of multiple sclerosis. Lancet. 343:1994;271-279.
2. Heber-Katz E. The relationship between human multiple sclerosis and rodent experimental allergic encephalomyelitis. Ann. NY. Acad. Sci. 756:1995;283-293.
3. Raine C.S. Analysis of autoimmune demyelination: Its impact upon multiple sclerosis. Lab. Invest. 50:1984;608-635.
4. Orr E.L. Presence and distribution of nervous system-associated mast cells that may modulate experimental autoimmune encephalomyelitis. Ann. NY Acad. Sci. 540:1988;723-726.
5. Bo L., Olsson T., Nyland H., Kruger P.G., Taule A., Mork S. Mast cells in brains during experimental allergic encephalomyelitis in Lewis rats. J. Neurol. Sci. 105:(2):1991;135-142.
6. Olsson Y. Mast cells in plaques of multiple sclerosis. Acta. Neurol. Scand. 50:1974;611-618.
7. Krüger P.G., Bo L., Myhr K.M., Karlsen A.E., Taule A., Nyland H.I., Mork S. Mast cells and multiple sclerosis: a light and electron microscopic study of mast cells in multiple sclerosis emphasizing staining procedures. Acta. Neurol. Scand. 81:1990;31-36.
8. 2 can stimulate mast cell degranulation. Brain Res. 444:1988;195-198.
9. Toms R., Weiner H.L., Johnson D. Identification of IgE-positive cells and mast cells in frozen sections of multiple sclerosis brains. J. Neuroimmunol. 30:1990;169-177.
10. Ibrahim M.Z.M., Reder A.T., Lawand R., Takash W., Sallouh-Khatib S. The mast cells of the multiple sclerosis brain. J. Neuroimmunol. 70:1996;131-138.
11. Bendele R.A., Adams E.R., Hoffman W.P., Gries C.L., Morton D.M. Carcinogenicity studies of fluoxetine hydrochloride in rats and mice. Cancer Res. 52:1992;6391-6395.
12. Theoharides T.C., Baloyannis S.J., Manolidis L.S. Activated rat peritoneal mast cells can cause syngeneic brain demyelination in vitro. Int. J. Immunopath. Pharmacol. 4:1991;137-144.
13. Dietsch G.N., Hinrichs D.J. Mast cell proteases liberate encephalitogenic fragments from intact myelin. Cell Immunol. 135:1991;541-548.
14. Theoharides T.C., Dimitriadou V., Letourneau R.J., Rozniecki J.J., Vliagoftis H., Boucher W.S. Synergistic action of estradiol and myelin basic protein on mast cell secretion and brain demyelination: changes resembling early stages of demyelination. Neuroscience. 57:1993;861-871.
15. Rodewald H.-R., Dessing M., Dvorak A.M., Galli S.J. Identification of a committed precursor for the mast cell lineage. Science. 271:1996;818-822.
16. Galli S.J. New concepts about the mast cell. N. Engl. J. Med. 328:1993;257-265.
17. Theoharides T.C. Mast cell: a neuroimmunoendocrine master player. Int. J. Tissue React. 18:1996;1-21.
18. Lambracht-Hall M., Dimitriadou V., Theoharides T.C. Migration of mast cells in the developing rat brain. Dev. Brain Res. 56:1990;151-159.
19. Dimitriadou V., Lambracht-Hall M., Reichler J., Theoharides T.C. Histochemical and ultrastructural characteristics of rat brain perivascular mast cells stimulated with compound 48/80 and carbachol. Neuroscience. 39:1990;209-224.
20. Dropp J.J. Mast cells in the mammalian brain. Part I. Distribution. Acta. Anat. 94:1976;1-21.
21. Edvinsson L., Cervos-Navarro J., Larsson L.I., Owman C., Ronnberg A.L. Regional distribution of mast cells containing histamine, dopamine or 5-hydroxytryptamine in the mammalian brain. Neurology. 27:1977;878-884.
22. Dropp J.J. Mast cells in the human brain. Acta. Anat. 105:1979;505-513.
23. Ibrahim M.Z., Al-Wirr M.E., Bahuth N. The mast cells of the mammalian central nervous system. Part III. Ultrastructural characteristics in the adult rat brain. Acta. Anat. 104:1979;134-154.
24. Olsson Y. Mast cells in the nervous system. Int. Rev. Cytol. 24:1968;27-70.
25. Ibrahim M.Z. The mast cells of the mammalian central nervous system. Part I. Morphology, distribution and histochemistry. J. Neurol. Sci. 21:1974;431-478.
26. Dimitriadou V., Rouleau A., Trung Tuong M.D., Newlands G.J.F., Miller H.R.P., Luffau G., Schwartz J.-C., Garbarg M. Functional relationships between sensory nerve fibers and mast cells of dura mater in normal and inflammatory conditions. Neuroscience. 77:1997;829-839.
27. Pang X., Letourneau R., Rozniecki J.J., Wang L., Theoharides T.C. Definitive characterization of rat hypothalamic mast cells. Neuroscience. 73:1996;889-902.
28. Dimitriadou V., Aubineau P., Taxi J., Seylaz J. Ultrastructural evidence for a functional unit between nerve fibers and type II cerebral mast cells in the cerebral vascular wall. Neuroscience. 22:1987;621-630.
29. Keller J.T., Dimlich R.V., Zuccarello M., Lanker L., Strauss T.A., Fritts M.J. Influence of the sympathetic nervous system as well as trigeminal sensory fibres on rat dural mast cells. Cephalalgia. 11:(5):1991;215-221.
30. Dimitriadou V., Buzzi M.G., Theoharides T.C., Moskowitz M.A. Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation. Neuroscience. 48:1992;187-203.
31. Theoharides T.C. Mast cells: the immune gate to the brain. Life Sci. 46:1990;607-617.
32. Linthicum D.S., Munoz J.J., Blaskett A. Acute experimental autoimmune encephalomyelitis in mice. Cell Immunol. 73:1982;299-310.
33. Zhuang X., Silverman A.-J., Silver R. Brain mast cell degranulation regulates blood-brain barrier. J. Neurobiol. 31:1996;393-403.
34. Kermode A.G., Thompson A.J., Tofts P., MacManus D.G., Kendall B.E., Kingsley D.P.E., Moseley I.F., Rudge P., McDonald W.I. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Brain. 113:1990;1477-1489.
35. Stone L.A., Smith M.E., Albert P.S., Bash C.N., Maloni H., Frank J.A., McFarland H.F. Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender, and age. Neurology. 45:1995;1122-1126.
36. Minogiannis P., El-Mansoury M., Betances J.A., Sant G.R., Theoharides T.C. Hydroxyzine inhibits neurogenic bladder mast cell activation. Int. J. Immunopharmacol. 20:1998;553-563.
37. v mice. Int. Arch. Allergy Immunol. 102:1993;352-361.
38. Askenase P.W., Van Loveren H. Delayed-type hypersensitivity: activation of mast cells by antigen-specific T-cell factors initiates the cascade of cellular interactions. Immunol. Today. 4:1983;259-264.
39. 1 receptor antagonist hydroxyzine. J. Allergy Clin. Immunol. 73:1984;69-75.
40. Theoharides T.C., Kops S.K., Bondy P.K., Askenase P.W. Differential release of serotonin without comparable histamine under diverse conditions in the rat mast cell. Biochem. Pharmacol. 34:1985;1389-1398.
41. Ting S., Rauls D.O., Reimann B.E. Inhibitory effect of hydroxyzine on antigen induced histamine release in vivo. J. Allergy Clin. Immunol. 75:1985;63-66.
42. 1-antagonist derived anti-allergic drugs: relation to lipophilicity and membrane effects. Inflamm. Res. 44:1995;92-97.
43. Theoharides T.C., Dimitriadou V., Massacesi L., Hauser S.L. Ultrastructural evidence of mast cell involvement in monkey experimental allergic ecephalomyelitis (EAE). Proc International Congress on Inflammation (Barcelona). 1990;282.
44. Stanley N.C., Jackson F.L., Orr E.L. Attenuation of experimental autoimmune encephalomyelitis by compound 48/80 in Lewis rats. J. Neuroimmunol. 29:1990;223-228.
45. Brenner T., Soffer D., Shalit M., Levi-Schaffer F. Mast cells in experimental allergic encephalomyelitis: characterization, distribution in the CNS and in vitro activation by myelin basic protein and neuropeptides. J. Neurol. Sci. 122:1994;210-213.
46. Seibold J.R., Giorno R.C., Claman H.N. Dermal mast cell degranulation in systemic sclerosis. Arthritis Rheum. 33:1990;1702-1709.
47. Powell H.C., Braheny S.L., Myers R.R., Rodriguez M., Lampert P.W. Early changes in experimental allergic neuritis. Lab. Invest. 48:1983;332-338.
48. Nilsson G., Butterfield J.H., Nilsson K., Siegbahn A. Stem cell factor is a chemotactic factor for human mast cells. J. Immunol. 153:1994;3717-3723.
49. Longley B.J. Jr, Morganroth G.S., Tyrrell L., Ding T.G., Anderson D.M., Williams D.E., Halaban R. Altered metabolism of mast-cell growth factor (c-kit Ligand) in cutaneous mastocytosis. N. Engl. J. Med. 328:1993;1302-1307.
50. Brown A., McFarlin D.E., Raine C.S. Chronologic neuropathy of relapsing experimental allergic encephalomyelitis in the mouse. Lab Invest. 46:1982;171-185.
51. Raine C.S., Traugott U. Experimental autoimmune demyelination chronic relapsing models and therapeutic implications for multiple sclerosis. Ann. NY Acad. Sci. 436:1984;33-51.
52. Aloe L., Levi-Montalcini R. Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Res. 133:1977;358-366.
53. Bienenstock J., Tomioka M., Matsuda H., Stead R.H., Quinonez G., Simon G.T., Coughlin M.D., Denburg J.A. The role of mast cells in inflammatory processes: evidence for nerve mast cell interactions. Int. Arch. Allergy Appl. Immunol. 82:1987;238-243.
54. Mazurek N., Weskamp G., Ernst P., Otten U. Nerve growth factor induces mast cell degranulation without changing intracellular calcium levels. FEBS Lett. 198:1986;315-320.
55. Matsuda H., Coughlin M.D., Bienenstock J., Denburg J.A. Nerve growth factor promotes human hemopoietic colony growth and differentiation. Proc. Natl. Acad. Sci., U.S.A. 85:1988;6508-6512.
56. Lambracht-Hall M., Konstantinidou A.D., Holdridge M., et al. Tricyclic compounds inhibit thalamic mast cell secretion. Soc. Neurosci. Abs. 14:1988;25. Abstract.
57. Moor A.C.E., de Vries H.E., de Boer A.G., Breimer D.D. The blood-brain barrier and multiple sclerosis. Biochem. Pharmacol. 47:1994;1717-1724.
58. de Vreis H.E., Kuiper J., de Boer A.G., van Berkel T.J.C., Breimer D.D. The blood-brain barrier in neuroinflammatory diseases. Pharmacol Rev. 49:1997;143-155.
59. Esposito P., Pang X., Boucher W. Acute psychological stress induces mast cell dependent increase in brain vascular permeability: implications for multiple sclerosis (MS). FASEB J. 13:1998;A326. Abstract.
60. Morh D.E. An association between stress and development of new lesions in the brain and spinal cord of individuals with MS. Proc. Ann. Mtg. Soc. Beh. Medicine :1998;. Abstract.
61. Serafin W.E., Austen K.F. Mediators of immediate hypersensitivity reactions. N. Engl. J. Med. 317:1987;30-34.
62. Olesen S.P. Leakeness of rat brain microvessels to fluorescent probes following craniotomy. Acta. Physiol. Scand. 130:1987;63-68.
63. Unterberg A., Wahl M., Hammersen F., Baethmann A. Permeability and vasomotor response of cerebral vessels during exposure to arachidonic acid. Acta. Neuropathol. 73:1987;209-219.
64. Schurer L., Temesvari P., Wahl M., Unterberg A., Baethmann A. Blood-brain barrier permeability and vascular reactivity to bradykinin after pretreatment with dexamethasone. Acta. Neuropathol. 77:1989;576-581.
65. Sharma H.S., Olsson Y., Dey P.K. Changes in blood-brain barrier and cerebral blood flow following elevation of circulating serotonin level in anesthetized rats. Brain Res. 517:1990;215-223.
66. Gordon J.R., Burd P.R., Galli S.J. Mast cells as a source of multifunctional cytokines. Immunol. Today. 11:1990;458-464.
67. Walsh L.J., Trinchieri G., Waldorf H.A., Whitaker D., Murphy G.F. Human dermal mast cells contain and release tumor necrosis factor α, which induces endothelial leukocyte adhesion molecule 1. Proc. Natl. Acad. Sci., U.S.A. 88:1991;4220-4224.
68. Cocchiara R., Bongiovanni A., Albeggiani G., Azzolina A., Geraci D. Evidence that brain mast cells can modulate neuroinflammatory responses by tumor necrosis factor-α production. Neuroreport. 9:1998;95-98.
69. Probert L., Akassoglou K., Kassiotis G., Pasparakis M., Alexopoulou L., Kollias G. TNF-α transgenic and knockout models of CNS inflammation and degeneration. J. Neuroimmunol. 72:1997;137-141.
70. Hartung H.-P., Reiners K., Archelos J.J., Michels M., Seeldrayers P., Heidenreich F., Pflughaupt K.W., Toyka K.V. Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging. Ann. Neurol. 38:1995;186-193.
71. Tsukada N., Matsuda M., Miyagi K., Yanagisawa N. Increased levels of intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor receptor in the cerebrospinal fluid of patients with multiple sclerosis. Neurology. 43:1993;2679-2682.
72. Sharief M.K., Noori M.A., Ciardi M., Cirelli A., Thompson E.J. Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-α and blood-brain barrier damage. J. Neuroimmunol. 43:1993;15-22.
73. Rieckmann P., Nünke K., Burchhardt M., Albrecht M., Wiltfang J., Ulrich M., Felgenhauer K. Soluble intercellular adhesion molecule-1 in cerebrospinal fluid: an indicator for the inflammatory impairment of the blood-cerebrospinal fluid barrier. J. Neuroimmunol. 47:1993;133-140.
74. Raine C.S., Lee S.C., Scheinberg L.C., Duijvestijn A.M., Cross A.H. Adhesion molecules on endothelial cells in the central nervous system: an emerging area in the neuroimmunology of multiple sclerosis. Clin. Immunol. Immunopathol. 57:1990;173-187.
75. Cannella B., Cross A.H., Raine C.S. Relapsing autoimmune demyelination: a role for vascular addressins. J. Neuroimmunol. 35:1991;295-300.
76. Raine C.S., Cannella B., Duijvestijn A.M., Cross A.H. Homing to central nervous system vasculature by antigen-specific lymphocytes. Part II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination. Lab. Invest. 63:1990;476-489.
77. Archelos J.J., Jung S., Mäurer M., Schmied M., Lassman H., Tamatani T., Miyasaka M., Toyka K.V., Hartung H.-P. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1. Ann. Neurol. 34:1993;145-154.
78. Dimitriadou V., Rouleau A., Tuong T., Ligneau X., Newlands G.F.J., Miller H.R.P., Schwartz J.-C., Garbarg M. Rat cerebral mast cells undergo phenotype changes during development. Dev. Brain Res. 97:1996;29-41.
79. Shin T., Kojima T., Tanuma N., Ishihara Y., Matsumoto Y. The subarachnoid space as a site for precursor T cell proliferation and effector T cell selection in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 56:1995;171-177.
80. vmice. FASEB J. 12:1998;1693-1700.
81. Hvas J., McLean C., Justesen J., Kannourakis G., Steinman L., Oksenberg J.R. Perivascular T cells express the pro-inflammatory chemokine RANTES MRNA in multiple sclerosis lesions. Scand. J. Immunol. 46:1997;195-203.
82. Shanas U., Bhasin R., Sutherland A.K., Silverman A.-J., Silver R. Brain mast cells lack the c-kit receptor: immunocytochemical evidence. J. Neuroimmunol. 90:1998;207-211.
83. Dietsch G.N., Hinrichs D.J. The role of mast cells in the elicitation of experimental allergic encephalomyelitis. J. Immunol. 142:1989;1476-1481.
84. Rozniecki J.J., Hauser S.L., Stein M., Lincoln R., Theoharides T.C. Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann. Neurol. 37:1995;63-66.
85. Theoharides T.C., Esposito P., Pang X., et al. Acute psychological stress induces mast cell dependent increase in brain vascular permeability:implications for multiple sclerosis (MS) and inhibition by hydroxyzine. European Conference on Biomedical Research and Peace. 1999;58. Abstract.